Gabapentin for the treatment of substance use disorders

Journal of Psychosocial Nursing and Mental Health Services

Volumn 51, Issue 12, 2013, Pages 11-14

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; TRANQUILIZER;

ADDICTION; ARTICLE; HUMAN; TREATMENT OUTCOME;

AMINES; ANTIMANIC AGENTS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84889594786     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20131120-01     Document Type: Article

References (19)

1. Anton, R.F., Myrick, H., Wright, T.M., Latham, P.K., Baros, A.M., Waid, L.R., & Randall, P.K. (2011). Gabapentin combined with naltrexone for the treatment of alcohol dependence. American Journal of Psychiatry, 168, 709-717. doi:10.1176/appi.ajp.2011.10101436
2. Berger, S.P., Winhusen, T.M., Somoza, E.C., Harrer, J.M., Mezinskis, J.P., Leiderman, D.B., Elkashef, A. (2005). A medication screening trial evaluation of reserpine, gabapentin, and lamotrigine pharmacotherapy of cocaine dependence. Addiction, 100(Suppl. 1), 58-67.
3. Bisaga, A., Aharonovich, E., Garawi, F., Levin, F.R., Rubin, E., Raby, W.N., & Nunes, E.V. (2006). A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence, 81, 267-274.
4. Bonnet, U., Hamzavi-Abedi, R., Specka, M., Wiltfang, J., Lieb, B., & Scherbaum, N. (2010). An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol and Alcoholism, 45, 143-145. doi:10.1093/alcalc/agp085
5. Brower, K.J., Myra Kim, H., Strobbe, S., Karam-Hage, M.A., Consens, F., & Zucker, R.A. (2008). A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcoholism, Clinical and Experimental Research, 32, 1429-1438. doi:10.1111/j.1530-0277.2008.00706.x
6. Bryans, J.S., & Wustrow, D.J. (1999). 3-substituted GABA analogs with central nervous system activity: A review. Medicinal Research Reviews, 19, 149-177.
7. Furieri, F.A., & Nakamura-Palacios, E.M. (2007). Gabapentin reduces alcohol consumption and craving: A randomized double-blind placebo-controlled trial. Journal of Clinical Psychiatry, 68, 1691-1700.
8. González, G., Desai, R., Sofuoglu, M., Poling, J., Oliveto, A., Gonsai, K., & Kosten, T.R. (2007). Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence, 87, 1-9.
9. Heinzerling, K.G., Shoptaw, S., Peck, J.A., Yang, X., Liu, J., Roll, J., & Ling, W. (2006). Randomized placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 85, 177-184.
10. Mariani, J.J., Rosenthal, R.N., Tross, S., Singh, P., & Anand, O.P. (2006). A randomized open-label controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. American Journal on Addictions, 15, 76-84.
11. Mason, B.J., Crean, R., Goodell, V., Light, J.M., Quello, S., Shadan, F., Rao, S. (2012). A proof-of-concept randomized controlled study of gabapentin: Effects on cannabis use, withdrawal and executive function deficits I cannabis-dependent adults. Neuropsychopharmacology, 37, 1689-1698. doi:10.1038/npp.2012.14
12. Mason, B.J., Quello, S., Goodell, V., Shadan, F., Kyle, M., & Begovic, A. (2013). Gabapentin treatment for alcohol dependence: A randomized clinical trial. JAMA Internal Medicine. Advance online publication. doi:10.1001/jamainternmed.2013.11950
13. Moghadam, M.S., & Alavinia, M. (2013). The effects of gabapentin on methadone based addiction treatment: A randomized controlled trial. Pakistan Journal of Pharmaceutical Sciences, 26, 985-989.
14. Myrick, H., Malcolm, R., Randall, P.K., Boyle, E., Anton, R.F., Becker, H.C., & Randall, C.L. (2009). A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcoholism, Clinical and Experimental Research, 33, 1582-1588. doi:10.1111/ j.1530-0277.2009.00986.x
15. Sanders, N.C., Mancino, M.J., Gentry, W.B., Guise, J.B., Bickel, W.K., Thostenson, J., & Oliveto, A.H. (2013). Randomized placebo-controlled pilot trial of gabapentin during an outpatient buprenorphine-assisted detoxification procedure. Experimental and Clinical Psychopharmacology, 21, 294-302. doi:10.1037/a0033724
16. Stewart, B.H., Kugler, A.R., Thompson, P.R., & Bockbrader, H.N. (1993). A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharmaceutical Research, 10, 276-281.
17. Stock, C.J., Carpenter, L., Ying, J., & Greene, T. (2013). Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Annals of Pharmacotherapy, 47, 961-969. doi:10.1345/aph.1R751
18. Taylor, C.P., Gee, N.S., Su, T.Z., Kocsis, J.D., Welty, D.F., Brown, J.P., Singh, L. (1998). A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research, 29, 233-249.
19. Yoshizumi, M., Eisenach, J.C., & Hayashida, K.I. (2012). Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes. European Journal of Pharmacology, 677, 87-92. doi:10.1016/j.ejphar.2011.12.015